Zim Laboratories Share Price

₹ 132.80

-₹3.49 (-2.56%)

Last updated 02 Nov, 2026, 15:29 IST

NSE: ZIMLAB

Zim Laboratories Share Price Today

As of 3 Nov 2026, Zim Laboratories share price is ₹132.80. The stock opened at ₹137.00, compared to its previous close of ₹136.29. During today's trading session, Zim Laboratories share price moved in the range of ₹132.60 to ₹137.67, with an average price of ₹135.13 for the day. Looking at its last 52-week, the stock has touched a low of ₹59.31 and a high of ₹159.81. On the performance front, Zim Laboratories share price has increased by 53.25% over the last six months and is up 84.01% on a year-on-year basis.

₹132.60

2.56% down today

₹137.67

1D LOW

1D HIGH

Zim Laboratories Stock Insights

Latest Earning

Op Profit TrendDown by 212.75% QoQ

Latest Earning

Net Profit TrendDown by 207.49% QoQ

Latest Earning

Revenue TrendUp by 0.25% YoY

Stock Performance

OutperformingBeat Nifty by 26.08 % in last 3 month

Shareholding Pattern

PromoterPromoter decreased stake by 0.19%

Shareholding Pattern

DIIDII decreased stake by 96.49%

Shareholding Pattern

FIIFII increased stake by 445.66%

Zim Laboratories Stock Insights

Latest Earning

Op Profit TrendDown by 212.75% QoQ

Latest Earning

Net Profit TrendDown by 207.49% QoQ

Latest Earning

Revenue TrendUp by 0.25% YoY

Stock Performance

OutperformingBeat Nifty by 26.08 % in last 3 month

Shareholding Pattern

PromoterPromoter decreased stake by 0.19%

Shareholding Pattern

DIIDII decreased stake by 96.49%

Shareholding Pattern

FIIFII increased stake by 445.66%

Zim Laboratories stock performance
Open	₹137.00
High	₹137.67
Low	₹132.60
Prev. close	₹136.29

Zim Laboratories trading activity
Volume	35,935
Average traded price	₹135.15
Last traded time	03:29:56 02 Nov
Last traded quantity	40

₹109.04₹163.54

Circuit Low

Circuit High

₹59.31₹159.81

52-Week Low

52-Week High

Circuit

₹109.04

₹163.54

52-week

₹59.31

₹159.81

Mkt Cap Cr

732.17

P/E

197.75

P/B

2.49

ROA

0.69%

ROE

1.97%

ROCE

5.07%

Quick Ratio

0.96

EV/EBITDA

20.83

Mkt Cap Cr

732.17

P/E

197.75

P/B

2.49

ROA

0.69%

ROE

1.97%

ROCE

5.07%

Quick Ratio

0.96

EV/EBITDA

20.83

Based on fundamentals, this stock's

Performance

Neutral

Zim Laboratories performance is moderate compared to markets

Valuation

Overvalued

Zim Laboratories appears overvalued compared to its peers

Earnings

Poor

Zim Laboratories earnings have been degrowing

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROA	ROE	ROCE	Quick Ratio	EV/EBITDA
Sun Pharmaceutical Industries	4,26,661.74	38.83	4.78	9.61%	13.79%	18.65%	2.31	22.27
Divis Laboratories	2,57,902.73	88.17	15.39	14.6%	15.32%	19.56%	3.5	58.97
Torrent Pharmaceuticals	1,76,306.21	84.0	9.6	4.7%	11.42%	11.37%	0.75	33.6
Laurus Labs	1,29,242.68	97.0	21.33	11.58%	22.11%	20.91%	0.68	54.77
Zydus Lifesciences	1,24,089.48	27.02	4.58	8.57%	18.59%	17.35%	0.91	16.42
Dr. Reddy's Laboratories	1,12,698.53	40.84	2.9	4.79%	7.21%	8.58%	1.35	19.05
Cipla	1,11,486.14	39.06	3.15	6.6%	8.18%	10.8%	2.5	21.03
Mankind Pharma	1,02,796.60	45.42	5.85	7.82%	12.76%	14.68%	0.74	25.01
Aurobindo Pharma	96,536.90	26.02	2.55	6.34%	9.25%	11.76%	1.15	12.38
Lupin	91,870.16	16.55	4.09	14.47%	23.76%	24.88%	1.42	9.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Zim Laboratories Company Background

ISIN

INE518E01015

Sector Market Cap

₹ 732.17 Cr

ZIM Laboratories Limited is a pharmaceutical company. The Company develops, manufactures and supplies oral, solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) in various therapeutic segments. Its delivery solutions cover product conceptualization product development, filing for registration, manufacture, and supply of various pharmaceutical formulations. It is developing products in various therapeutic segments like, central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology and vitamins, minerals, and dietary supplements. Its technological capabilities include drug release modification, solubility and stability enhancement, taste masking and dosage form transformation. Its product offerings include finished formulations and pre-formulations intermediates, which include granules, pellets, taste-masked powders, dry suspensions, tablets, capsules, and oral thin films.

Zim Laboratories Financial Highlights

Revenue: Zim Laboratories reported revenue of ₹385.78 crore in FY26 vs ₹384.81 crore in FY25. It showed an increase of 0.25% on a yearly basis.
Operating Profit: Zim Laboratories reported an operating profit of ₹8.21 crore in FY26 vs ₹18.01 crore in FY25. It showed a decrease of 54.41% on a year-on-year basis.
Net Profit: Zim Laboratories reported a net profit of ₹5.84 crore in FY26 vs ₹12.17 crore in FY25. It showed a decrease of 52.01% on a yearly basis.

Zim Laboratories Quarterly Result Highlights

Zim Laboratories reported revenue of ₹95.17 crore in Jun 2026, compared with ₹111.43 crore in Mar 2026, representing a decrease of 14.59% on a quarter-on-quarter (QoQ) basis.
Zim Laboratories reported an operating loss of ₹5.57 crore in Jun 2026, compared with ₹4.94 crore in Mar 2026, representing a decrease of 212.75% on a quarter-on-quarter (QoQ) basis.
Zim Laboratories reported a loss of ₹4.02 crore in Jun 2026, compared with ₹3.74 crore in Mar 2026, reflecting a decrease of 207.49% on a QoQ basis.
The earnings per share (EPS) of Zim Laboratories stood at ₹1.19 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters

30.30%

FII

0.17%

Other DII

0.01%

Retail and other

68.34%

Mutual funds

1.18%

Foreign Institutional Investor (FII)

FII shareholding by period
Dec 2025	0.02%
Mar 2026	0.00%
Jun 2026	0.03%
Sep 2026	0.17%

Zim Laboratories Investment Returns

1 day

-1.12%

1 week

+6.38%

1 month

-1.64%

1 year

+84.01%

3 years

+12.68%

5 years

+20.19%

Zim Laboratories Share Price History

Zim Laboratories share price history by day, showing open and close prices and the percentage change
Day	Open / Close	Change %
02 Nov 26	₹137.00 / ₹132.80	-2.56%
30 Oct 26	₹134.63 / ₹136.29	-0.18%
29 Oct 26	₹140.10 / ₹136.54	-3.34%
28 Oct 26	₹130.35 / ₹141.26	+5.56%
27 Oct 26	₹126.60 / ₹133.82	+5.63%
26 Oct 26	₹125.20 / ₹126.69	+0.37%
23 Oct 26	₹130.80 / ₹126.22	-4.47%
22 Oct 26	₹130.63 / ₹132.12	-0.13%
21 Oct 26	₹138.20 / ₹132.29	-4.26%
19 Oct 26	₹145.60 / ₹138.17	-4.55%

Zim Laboratories Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹374.40	₹379.03	₹367.42	₹398.53
Other Income	₹11.38	₹5.78	₹5.18	₹6.41
Total Revenue	₹385.78	₹384.82	₹372.61	₹404.94
Total Expenses	₹377.57	₹366.81	₹348.97	₹369.59
Profit Before Tax	₹8.21	₹18.01	₹23.64	₹35.36
Tax	₹2.37	₹5.84	₹6.40	₹10.92
Profit After Tax	₹5.84	₹12.17	₹17.25	₹24.43
EPS - Basic	₹1.19	₹2.50	₹3.54	₹5.01
EPS - Diluted	₹1.19	₹2.50	₹3.54	₹5.01

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹8.21	₹18.01	₹23.64	₹35.36
Income before WC changes	₹37.31	₹51.64	₹45.65	₹57.51
Change in Assets	-₹7.30	-₹5.21	-₹34.69	₹24.27
Change in Liabilities	₹23.26	-₹6.36	₹7.91	-₹37.11
Change in WC	₹15.96	-₹11.57	-₹26.79	-₹12.84
Cash flow from Operations	₹49.53	₹41.15	₹16.28	₹37.52
Cash flow from Investing	-₹56.35	-₹39.93	-₹73.01	-₹36.20
Cash flow from Financing	₹28.19	-₹9.10	₹59.53	₹0.55
Total Cash Flow	₹23.18	-₹7.65	₹3.18	₹3.00
Cash (Start of the year)	₹1.95	₹9.60	₹6.42	₹3.42
Cash (End of the year)	₹25.12	₹1.95	₹9.60	₹6.42

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹263.58	₹240.97	₹219.17	₹150.63
Current Assets	₹275.81	₹231.31	₹227.65	₹190.95
Total Assets	₹539.39	₹472.27	₹446.82	₹341.58
Current Liabilities	₹190.39	₹166.36	₹159.43	₹110.79
Net Current Asset	₹85.42	₹64.94	₹68.22	₹80.16
Non-Current Liabilities	₹52.84	₹53.67	₹48.65	₹30.45
Equity Capital	₹296.15	₹252.24	₹238.75	₹200.35
Total Equity & Liabilities	₹539.39	₹472.27	₹446.82	₹341.58

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹370.48	₹375.64	₹365.47	₹396.53
Other Income	₹11.39	₹5.62	₹4.69	₹6.43
Total Revenue	₹381.87	₹381.26	₹370.16	₹402.96
Total Expenses	₹373.47	₹363.64	₹347.12	₹367.04
Profit Before Tax	₹8.40	₹17.61	₹23.04	₹35.92
Tax	₹2.44	₹5.87	₹6.28	₹10.91
Profit After Tax	₹5.97	₹11.74	₹16.76	₹25.01
EPS - Basic	₹1.22	₹2.41	₹3.44	₹5.13
EPS - Diluted	₹1.22	₹2.41	₹3.44	₹5.13

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹8.40	₹17.61	₹23.04	₹35.92
Income before WC changes	₹36.10	₹50.28	₹44.40	₹56.73
Change in Assets	₹4.59	-₹5.50	-₹41.53	₹22.54
Change in Liabilities	₹10.56	₹4.53	₹11.17	-₹37.06
Change in WC	₹15.16	-₹0.97	-₹30.36	-₹14.52
Cash flow from Operations	₹47.66	₹50.60	₹11.47	₹35.23
Cash flow from Investing	-₹57.41	-₹41.31	-₹71.94	-₹35.21
Cash flow from Financing	₹28.19	-₹9.10	₹59.53	₹0.55
Total Cash Flow	₹18.43	₹0.19	-₹0.94	₹0.57
Cash (Start of the year)	₹0.36	₹0.17	₹1.11	₹0.54
Cash (End of the year)	₹18.80	₹0.36	₹0.17	₹1.11

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹272.77	₹248.04	₹224.79	₹156.23
Current Assets	₹252.43	₹216.35	₹217.71	₹178.64
Total Assets	₹525.20	₹464.39	₹442.50	₹334.87
Current Liabilities	₹186.01	₹166.20	₹161.90	₹110.24
Net Current Asset	₹66.42	₹50.15	₹55.82	₹68.40
Non-Current Liabilities	₹52.84	₹53.67	₹48.65	₹30.45
Equity Capital	₹286.35	₹244.51	₹231.95	₹194.18
Total Equity & Liabilities	₹525.20	₹464.39	₹442.50	₹334.87